Background
==========

Hypoxia induces the transcription of various genes involved in angiogenesis and anaerobic metabolism necessary for the growth of tumor cells. Hypoxia-inducible factor 1 alpha (HIF-1α) regulates genes involved in the response to hypoxia and promotes neo-angiogenesis in cancer. Thus, to develop an anticancer agent with anti-angiogenic activity in hypoxic cancer cells, 6-(1-oxobutyl)-5,8-dimetoxy-1,4-naphthoquinone (OXO) was synthesized.

Methods
=======

The XTT (2,3-bis \[2-methoxy-4-nitro-5-sulfophenyl\]-2H-tetra-zolium-5-carboxanilide) assay for cytotoxicity, the ELISA, RT-PCR and western blotting analysis were employed in MCF-7 human breast cancer cells under hypoxic conditions.

Results
=======

OXO showed cytotoxicity against MCF-7 cells, human breast M. OXO also reduced the levels cancer cells with an IC~50~value of 10 μ of vascular endothelial cell growth factor (VEGF) and HIF-1α in MCF cells exposed to hypoxia. Similarly, OXO downregulated the expression of HIF-1 and VEGF by western blotting and RT-PCR. In addition, OXO inhibited the basic fibroblast growth factor (bFGF)-induced proliferation, inhibited tube formation of human umbilical vein endothelial cells (HUVECs) and also disrupted the neovascularization in bFGF-treated Matrigel *in vivo*.

Conclusion
==========

Taken together, these results show that OXO may exert anti-tumor and anti-angiogenic activity against MCF-7 cells via regulation of HIF-1α and VEGF.
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